These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38029550)
21. High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors. Lee GJ; Lee H; Woo IS; Kim T; An HJ; Choi HJ; Lee YS; Lee KY; Lee J; Kang JH Lung Cancer; 2019 Jun; 132():9-16. PubMed ID: 31097100 [TBL] [Abstract][Full Text] [Related]
22. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma. Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465 [TBL] [Abstract][Full Text] [Related]
23. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Test Accuracy of 18F-FDG PET or PET/CT for Characterization of Histologic Type of Thymic Epithelial Tumor: A Meta-analysis. Kim K; Jeong JH; Kim SJ Clin Nucl Med; 2022 Jan; 47(1):36-42. PubMed ID: 34661556 [TBL] [Abstract][Full Text] [Related]
25. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of standardised uptake value (SUV Yilmaz Demirci N; Yilmaz Ü; Biner Uslu I; Dikmen A; Yılmaz A; Erdoğan Y Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26988938 [TBL] [Abstract][Full Text] [Related]
27. Characterization of thymic masses using (18)F-FDG PET-CT. Kumar A; Regmi SK; Dutta R; Kumar R; Gupta SD; Das P; Halanaik D; Jindal T Ann Nucl Med; 2009 Aug; 23(6):569-77. PubMed ID: 19585212 [TBL] [Abstract][Full Text] [Related]
28. Correlation of 18F-FDG PET/CT SUVmax with clinical features, D-dimer and LDH in patients with primary intestinal lymphoma. Zhou S; Chen W; Lin M; Chen G; Chen C; Huo C; Du X J Int Med Res; 2021 Jul; 49(7):3000605211029809. PubMed ID: 34250823 [TBL] [Abstract][Full Text] [Related]
29. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317 [TBL] [Abstract][Full Text] [Related]
30. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms? Viti A; Terzi A; Bianchi A; Bertolaccini L Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms. Shinya T; Tanaka T; Soh J; Matsushita T; Sato S; Toyooka S; Yoshino T; Miyoshi S; Kanazawa S Acta Med Okayama; 2017 Apr; 71(2):105-112. PubMed ID: 28420891 [TBL] [Abstract][Full Text] [Related]
32. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors. Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H Eur J Cardiothorac Surg; 2011 Jul; 40(1):143-5. PubMed ID: 20951602 [TBL] [Abstract][Full Text] [Related]
33. Multiparameter diagnostic model based on Wang G; Du L; Lu X; Liu J; Zhang M; Pan Y; Meng X; Xu X; Guan Z; Yang J BMC Cancer; 2022 Aug; 22(1):895. PubMed ID: 35974323 [TBL] [Abstract][Full Text] [Related]
34. Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage? Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Agarwal JP; Prabhash K; Noronha V; Joshi A; Kumar R; Rangarajan V Indian J Cancer; 2016; 53(2):270-273. PubMed ID: 28071625 [TBL] [Abstract][Full Text] [Related]
35. Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma. Hu B; Xiao J; Xiu Y; Fu Z; Shi H; Cheng D Nucl Med Commun; 2020 Mar; 41(3):252-259. PubMed ID: 32068670 [TBL] [Abstract][Full Text] [Related]
36. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT. Yabuuchi H; Matsuo Y; Abe K; Baba S; Sunami S; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Nagao M; Okamoto T; Nakamura K; Yamamoto H; Sasaki M; Honda H Clin Radiol; 2015 Nov; 70(11):1289-98. PubMed ID: 26272529 [TBL] [Abstract][Full Text] [Related]
37. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. Sasaki M; Kuwabara Y; Ichiya Y; Akashi Y; Yoshida T; Nakagawa M; Murayama S; Masuda K J Nucl Med; 1999 Oct; 40(10):1595-601. PubMed ID: 10520697 [TBL] [Abstract][Full Text] [Related]
38. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670 [TBL] [Abstract][Full Text] [Related]
39. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours. Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437 [TBL] [Abstract][Full Text] [Related]
40. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors. Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]